News Agency
Men's Weekly

GenFleet Therapeutics Announces FDA's Clinical Trial Approval for GFH925 (KRAS G12C Inhibitor) Monotherapy in Phase III Registrational Study Treating Metastatic Colorectal Cancer

  • Written by PR Newswire

SHANGHAI, April 19, 2024 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Administration (FDA) has granted the clinical trial approval for GFH925 (KRAS G12C inhibitor) in a multi-center, open-label, randomized and controlled phase...

Read more: GenFleet Therapeutics Announces FDA's Clinical Trial Approval for GFH925 (KRAS G12C Inhibitor)...

How Recruitment Agencies Sydney Help Businesses Find the Right Talent

Hiring the right employees is one of the most important responsibilities for any organisation. Companies need skilled professionals who can contribute to business growth, maintain productivity, and strengthen workplace culture. However, finding the right candidates can be time-consuming and challenging... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion